These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18803127)

  • 1. [Photodynamic therapy in retinal pigment epithelium detachment associated with long term central serous chorioretinopathy].
    Borque E; Ruiz O; Torrón C; Ferrer E; Alías E
    Arch Soc Esp Oftalmol; 2008 Sep; 83(9):545-8. PubMed ID: 18803127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular photodynamic therapy for serous macular detachment in the diffuse retinal pigment epitheliopathy variant of idiopathic central serous chorioretinopathy.
    Canakis C; Livir-Rallatos C; Panayiotis Z; Livir-Rallatos G; Persidis E; Conway MD; Peyman GA
    Am J Ophthalmol; 2003 Oct; 136(4):750-2. PubMed ID: 14516825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal pigment epithelial tear after half fluence PDT for serous pigment epithelial detachment in central serous chorioretinopathy.
    Kim SW; Oh J; Oh IK; Huh K
    Ophthalmic Surg Lasers Imaging; 2009; 40(3):300-3. PubMed ID: 19485297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated pigment epithelium detachment: evidence for relation to central serous chorioretinopathy and effect of photodynamic therapy.
    Arif F; Pryds A; Larsen M
    Acta Ophthalmol; 2018 Dec; 96(8):821-827. PubMed ID: 30246489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy.
    Shinojima A; Kawamura A; Mori R; Fujita K; Yuzawa M
    Retina; 2011 Oct; 31(9):1912-20. PubMed ID: 21952105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Central serous chorioretinopathy and serous detachment of the pigmentary epithelium. Pathogeny relations].
    Munteanu G; Munteanu M
    Oftalmologia; 2003; 58(3):80-4. PubMed ID: 14702739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment.
    Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M
    Int Ophthalmol; 2017 Jun; 37(3):483-489. PubMed ID: 27392913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Photodynamic therapy for treatment of chronic or recurrent central serous chorioretinopathy].
    Li L; Yuan F; Xu GZ; Wang WJ
    Zhonghua Yan Ke Za Zhi; 2012 Feb; 48(2):106-13. PubMed ID: 22490944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Photodynamic therapy in severe chronic central serous chorioretinopaty].
    Reche-Frutos J; Calvo-González C; Donate-López J; Sáenz-Francés-San-Baldomero F; Cerván-López I; García-Feijoó J; García-Sánchez J
    Arch Soc Esp Oftalmol; 2008 Jan; 83(1):9-14. PubMed ID: 18188789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy.
    Ober MD; Yannuzzi LA; Do DV; Spaide RF; Bressler NM; Jampol LM; Angelilli A; Eandi CM; Lyon AT
    Ophthalmology; 2005 Dec; 112(12):2088-94. PubMed ID: 16325707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Photodynamic therapy for chronic central serous chorioretinopathy and diffuse retinal epitheliopathy].
    Cornut PL; Quaranta-El Maftouhi M; Mauget-Faÿsse M
    J Fr Ophtalmol; 2012 Feb; 35(2):82-7. PubMed ID: 21889817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relation between retinal pigment epithelial detachment and dye leakage in central serous retinopathy].
    Constantinides G
    J Fr Ophtalmol; 2000 Sep; 23(7):649-54. PubMed ID: 10992059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choroidal capillary and venous congestion in central serous chorioretinopathy.
    Prünte C; Flammer J
    Am J Ophthalmol; 1996 Jan; 121(1):26-34. PubMed ID: 8554078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced-fluence photodynamic therapy for subfoveal serous pigment epithelial detachment with choroidal vascular hyperpermeability.
    Goto S; Gomi F; Ueno C; Nishida K
    Am J Ophthalmol; 2012 Nov; 154(5):865-871.e1. PubMed ID: 22840480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central serous chorioretinopathy.
    Wang M; Munch IC; Hasler PW; Prünte C; Larsen M
    Acta Ophthalmol; 2008 Mar; 86(2):126-45. PubMed ID: 17662099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of macular serous neuroretinal detachment in tilted disk syndrome: report of 3 cases.
    Donati MC; Miele A; Abbruzzese G; Giuntoli M; Giansanti F; Menchini U
    Eur J Ophthalmol; 2013; 23(2):267-70. PubMed ID: 23225087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy for chronic central serous chorioretinopathy.
    Cardillo Piccolino F; Eandi CM; Ventre L; Rigault de la Longrais RC; Grignolo FM
    Retina; 2003 Dec; 23(6):752-63. PubMed ID: 14707823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes.
    Matušková V; Vysloužilová D; Uher M
    Semin Ophthalmol; 2018; 33(5):690-699. PubMed ID: 29252091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choroidal neovascularization following photodynamic therapy in a patient with chronic central serous chorioretinopathy.
    Yaman A; Arikan G; Saatci AO; Cingil G
    Bull Soc Belge Ophtalmol; 2007; (303):69-73. PubMed ID: 17894291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic central serous chorioretinopathy and photodynamic therapy: a case report].
    Thomas F; Berthout A; Malthieu D; Turut P; Milazzo S
    J Fr Ophtalmol; 2008 Dec; 31(10):e21. PubMed ID: 19107068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.